October 2024: Global Training on RCTs and RWE for Novartis Medical Teams

In October 2024, we had the privilege of delivering a global training session for Novartis medical teams spanning multiple regions, including Asia, China, Canada, LATAM, and beyond. This virtual event brought together professionals from across the globe to enhance their understanding of Randomised Controlled Trials (RCTs) and Real-World Evidence (RWE), two crucial methodologies in modern clinical research.

The session focused on providing insights into how RCTs and RWE complement each other in generating evidence that informs clinical decision-making. Through a series of expert-led discussions, case studies, and interactive modules, participants gained a deeper understanding of:

• The role of RCTs as the gold standard in clinical trials and their application in clinical practice
• How to effectively interpret and apply RWE, particularly in real-world healthcare settings
• The regional considerations and challenges when designing studies and applying evidence across diverse populations
• Best practices for integrating both RCTs and RWE to drive more informed, patient-centered decision-making

Bringing together medical professionals from a wide range of regions offered a unique opportunity to share different perspectives, challenges, and solutions, creating an enriching learning environment that fostered global collaboration.

We are proud to have supported Novartis’ global medical teams in strengthening their ability to evaluate and utilize clinical evidence to improve patient outcomes around the world.

Looking to enhance your team’s expertise in RCTs, RWE, or evidence-based medicine? Contact us to explore our tailored training options for teams worldwide.